This dual benefit makes Semaglutide ideal for those who want to quit smoking and lose weight simultaneously
For dosing guidance after purchase, our semaglutide dosage chart in units and optimal timing guide cover everything you need for proper administration
Individual variation in skin sensitivity and vascular integrity means some patients never bruise while others do with every shot

Amylin/Calcitonin Receptor Agonism (cagrilintide) Delays gastric emptying, reduces postprandial glucagon, and strongly promotes satiety Modulates appetite-regulating centers in the hindbrain, hypothalamus, and brain reward circuits, directly influencing food intake and choice May transiently activate the renin-angiotensin-aldosterone system with dose escalation, but without blood pressure or electrolyte derangements GLP-1 Receptor Agonism (semaglutide) Stimulates glucose-dependent insulin secretion and suppresses glucagon release to improve glycemic control Reduces appetite and ad libitum energy intake, with central effects on GLP-1R-expressing nuclei in hypothalamus and brainstem Delays gastric emptying and increases satiety, contributing to progressive bodyweight loss Pharmacokinetic Profile Route of Administration Subcutaneous Dosing Frequency Once weekly Route of Administration : Subcutaneous Injection Dosing Frequency: Once weekly Half -life: Cagrilintide: 7-8 days

Open Field Test (OFT) The test followed the procedure outlined by Hall and Ballachey (1932), using a wooden box with dimensions of 40 40 cm for the floor and walls measuring 35 cm in height